White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis

BACKGROUND AND PURPOSE: Natalizumab treatment strongly affects relapsing-remitting multiple sclerosis, possibly by restraining white matter damage. This study investigated changes in white matter diffusivity in patients with relapsing-remitting multiple sclerosis during their first year of natalizum...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AJNR Am J Neuroradiol
Main Authors: Wiebenga, O.T., Schoonheim, M.M., Hulst, H.E., Nagtegaal, G.J.A., Strijbis, E.M.M., Steenwijk, M.D., Polman, C.H., Pouwels, P.J.W., Barkhof, F., Geurts, J.J.G.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Neuroradiology 2016
Assuntos:
Adult Brain
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7963536/
https://ncbi.nlm.nih.gov/pubmed/26965463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A4690
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados